The UK BioIndustry Association (BIA) welcomes key measures in today’s Autumn Budget that support the growth of life science ...

In a complex regulatory environment, post-market surveillance is a continuous process that demands precision, adaptability ...

Gilead licences Sprint Bioscience’s pre-clinical TREX1 inhibitor programme, gaining a novel immuno-oncology asset targeting ...

VANCOUVER, BC / ACCESS Newswire / November 26, 2025 / Lir Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has engaged MCS Market Communication ...

CHARLOTTE, NC / ACCESS Newswire / November 26, 2025 / First Care Medical Clinic is proud to announce its recognition as the Best Primary & Urgent Care Clinic in Charlotte, NC for 2025 by leading ...

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 26, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced that it has entered into a securities ...

New Industry Aims to Create U.S. Manufacturing Jobs While Supporting Colombian Farmers Transitioning to Legal, High-Value Hemp Production CALI, COLOMBIA / ACCESS Newswire / November 26, 2025 / ...

Moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Wednesday, December 3rd at 4:00 PM ET IRVINE, CA / ACCESS Newswire / November 26, 2025 / enVVeno Medical Corporation ...

Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted ...

ATHENS, GEORGIA / ACCESS Newswire / November 26, 2025 / In response to the devastating outbreak of Equine Herpesvirus-1 (EHV-1) linked to the WPRA event in Waco, Texas, Good Salt Life, Inc., a wholly ...

VANCOUVER, WASHINGTON / ACCESS Newswire / November 26, 2025 / Sinceri Senior Living is pleased to announce the continued expansion of its national foot, print through the transition and management of ...

ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, ...